Jurrien M. ten Berg

Showing 1-13 of 13 articles

Coronary interventions

Impact of presentation and transfer delays on complete ST-segment resolution before primary percutaneous coronary intervention: insights from the ATLANTIC trial

Fabris E, van’t Hof A, Hamm C, Lapostolle F, Flensted Lassen J, Goodman S, ten Berg J, Bolognese L, Cequier A, Chettibi M, Hammett C, Huber K, Janzon M, Merkely B, Storey R, Zeymer U, Cantor W, Rousseau H, Vicaut E, Montalescot G

May 15, 2017 | 10.4244/EIJ-D-16-00965

Interventions for valvular disease

Complete blood flow obstruction due to a distally embolised Edwards SAPIEN valve prosthesis

Nijenhuis V, Swaans M, ten Berg J

December 9, 2016 | 10.4244/EIJ-D-16-00064

Uninterrupted oral anticoagulation versus bridging in patients with long-term oral anticoagulation during percutaneous coronary intervention: subgroup analysis from the WOEST trial

Dewilde W, Janssen P, Kelder J, Verheugt F, de Smet B, Adrianssens T, Vrolix M, Brueren G, Vandendriessche T, Van Mieghem C, Cornelis K, Vos J, Breet N, ten Berg J

August 20, 2015 | 10.4244/EIJY14M06_07

Late catch-up in lumen diameter at five-year angiography in MACE-free patients treated with sirolimus-eluting stents in the Primary Stenting of Totally Occluded Native Coronary Arteries: a randomised comparison of bare metal stent implantation with sirolimus-eluting stent implantation for the treatment of total coronary occlusions (PRISON II)

Teeuwen K, Van den Branden B, Rahel B, Laarman G, Thijssen J, Kelder J, Slagboom T, ten Berg J, Suttorp MJ

June 28, 2013 | 10.4244/EIJV9I2A36

A randomised study of dabigatran in elective percutaneous coronary intervention in stable coronary artery disease patients

Vranckx P, Verheugt F, de Maat MP, Ulmans V, Regar E, Smits P, ten Berg J, Lindeboom W, Jones R, Friedman J, Reilly P, Leebeek F

January 18, 2013 | 10.4244/EIJV8I9A162

Five-year clinical outcome after primary stenting of totally occluded native coronary arteries: a randomised comparison of bare metal stent implantation with sirolimus-eluting stent implantation for the treatment of total coronary occlusions (PRISON II study)

Van den Branden B, Rahel B, Laarman G, Slagboom T, Kelder J, ten Berg J, Suttorp MJ

February 21, 2012 | 10.4244/EIJV7I10A190

Higher efficacy of pre-hospital tirofiban with longer pre-treatment time to primary PCI: protection for the negative impact of time delay

Heestermans A, de Boer M, van Werkum J, Mosterd A, Gosselink A, Dambrink J, van Houwelingen K, Koopmans P, Hamm C, Zijlstra F, ten Berg J, van’t Hof A

August 30, 2011 | 10.4244/EIJV7I4A73

Comparison of outcome after patent foramen ovale closure in older versus younger patients

Luermans J, Budts W, ten Berg J, Plokker H, Suttorp MJ, Post M

June 30, 2011 | 10.4244/EIJV7I2A35

Triggering mechanisms of stent thrombosis

Zwart B, van Werkum J, Heestermans A, Kelder J, Zomer A, van’t Hof A, Verheugt F, ten Berg J

January 20, 2011

Long-term outcome of percutaneous closure of secundum-type atrial septal defects in adults

Luermans J, Post M, ten Berg J, Plokker H, Suttorp MJ

November 15, 2010

The BioSTAR® device versus the CardioSEAL® device in patent foramen ovale closure: comparison of mid-term efficacy and safety

Van den Branden B, Luermans J, Post M, Plokker H, ten Berg J, Suttorp MJ

September 30, 2010

Pre-hospital administration of tirofiban in diabetic patients with ST-elevation myocardial infarction undergoing primary angioplasty: a sub-analysis of the On-Time 2 trial

Timmer J, ten Berg J, Heestermans A, Dill T, van Werkum J, Dambrink J, Suryapranata H, Ottervanger J, Hamm C, van’t Hof A

August 15, 2010

Triple therapy: the future or from the past?

Dewilde W, Breet N, ten Berg J

January 15, 2010

Latest news

New issue

EHRA/EAPCI consensus on LAA occlusion, EAPCI Position paper on defining device sucess and more

(3D volume-rendered CCTA LAA example)

January 17, 2020

Editorial

From Paris to Amsterdam: EuroPCR, ESC 2020 and spotlight on “The Cutting Edge of Cardiology”

Robert Byrne

January 17, 2020

JAA

New this week: Comparing OFR & FFR, Provisional bifurcation stenting procedure and more

January 21, 2020

TRIALS BOOK

Access some of the latest Trials: EXCEL 5 years, GALILEO, ISAR-REACT 5 ...

(The Trials book is supported by Biotronik)

January 15, 2020

Guidance Papers

Guidelines, consensus & position papers

April 9, 2019

Editorial

The role of the Heart Team in the planning of aortic valve replacement

January 15, 2020

JAA

Last week's JAA's: Inferior caval valve implantation for severe tricuspid regurgitation

Jurrien M. ten Berg

Latest news

Coronary

Valvular disease

Heart failure

Peripheral

Hypertension

Stroke